Venture Round - LIfT BioSciences

Venture Round - LIfT BioSciences

Investment Firm

Overview

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Announced Date

Dec 19, 2022

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Starbloom Capital

Starbloom Capital

Starbloom Capital is a early_stage_venture firm.

Participant Investors

1

Investor Name
Participant InvestorStarbloom Capital

Round Details and Background

LIfT BioSciences raised an undisclosed amount on 2022-12-19 in Venture Round

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 14, 2019
Series A - LIfT BioSciences
2-2.4M
May 24, 2018
Non Equity Assistance - LIfT BioSciences
1-undefined
Dec 19, 2022
Venture Round - LIfT BioSciences
1-undefined
May 16, 2024
Grant - LIfT BioSciences
1-1.3M

Recent Activity

There is no recent news or activity for this profile.